302 filings
Page 3 of 16
8-K
uovipk
17 Jun 21
Departure of Directors or Certain Officers
4:11pm
8-K
15smr
12 May 21
Cyclacel Pharmaceuticals Reports FIRST Quarter 2021 Financial Results
4:21pm
8-K
sor2joazqbdp5n
24 Mar 21
Other Events
12:00am
8-K
5i7ocfz4da75n4rg9de
15 Mar 21
Cyclacel Pharmaceuticals Prices $12.65 Million
5:21pm
8-K
1i1adz
25 Feb 21
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
4:21pm
8-K
qgdh1s9oli
24 Feb 21
Departure of Directors or Certain Officers
12:00am
8-K
z18x zub3p4w2
15 Jan 21
Departure of Directors or Certain Officers
4:06pm
8-K
4l6xqpo0j
22 Dec 20
Cyclacel Pharmaceuticals ANNOUNCES At-the-market $7 MILLION strategic INVESTMENT BY FUNDAMENTAL INVESTOR ACORN BIOVENTURES
4:05pm
8-K
o3d6k g69f2dxo9jhb
21 Dec 20
WAS ELECTEd TO ITS BOARD OF DIRECTORS
4:46pm
8-K
i08fx zlic
18 Dec 20
Other Events
12:00am
8-K
hzzwtpkqoxl1b2ye2559
12 Nov 20
Cyclacel Pharmaceuticals Reports THIRD Quarter 2020 Financial Results
8:47am
8-K
seg2efo0 tp3j7hv19
29 Oct 20
Cyclacel Pharmaceuticals ANNOUNCES APPOINTMENT OF MARK KIRSCHBAUM, m.d., AS CHIEF MEDICAL OFFICER
4:06pm
8-K
i5vse5t21okfbw76
15 Sep 20
Other Events
4:15pm
8-K
jd34wf2rfm neb
9 Sep 20
Departure of Directors or Certain Officers
4:30pm
8-K
70naq
2 Sep 20
Other Events
5:04pm
8-K
6rgweb3uq4c5 2icu
26 Aug 20
Other Events
5:08pm
8-K
pdy a3mhr9advtnbukv7
12 Aug 20
Cyclacel Pharmaceuticals Reports SECOND Quarter 2020 Financial Results
4:16pm
8-K
ivb0jupbp raz4z
29 Jun 20
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
5t6lf
12 May 20
Cyclacel Pharmaceuticals Reports FIRST Quarter 2020 Financial Results
4:15pm
8-K
xnv0yx
7 May 20
Amendments to Articles of Incorporation or Bylaws
4:02pm